When it comes to diet-induced obesity, your immune system is not always your friend.

The first Flexner Discovery Lecture of the academic year featured presentations by two Vanderbilt faculty members.

The Flexner Discovery Lecture series kicks off the academic year next week with presentations by two Vanderbilt faculty members. The Cutting-Edge Discovery Lectures by Meena Madhur, MD, PhD, and Scott Smith, MD, PhD, begin at 4 p.m. on Thursday, Aug. 30 in 208 Light Hall.

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

Vanderbilt University Medical Center’s Diagnostic Laboratories continue to expand in-house services in order to more efficiently diagnose and treat patients. A recent survey indicates clinicians’ overall satisfaction with the efforts.

Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections.